O	0	11	Suppression	Suppression	NN	B-NP
O	12	15	and	and	CC	O
O	16	18	re	re	AFX	B-NP
O	18	19	-	-	HYPH	I-NP
O	19	29	expression	expression	NN	B-NP
O	30	32	of	of	IN	B-PP
O	33	44	transformed	transform	VBN	B-NP
O	45	54	phenotype	phenotype	NN	I-NP
O	55	57	in	in	IN	B-PP
B-Cell	58	65	hybrids	hybrid	NNS	B-NP
O	66	68	of	of	IN	B-PP
O	69	71	HA	HA	NN	B-NP
O	71	72	-	-	HYPH	B-NP
O	72	75	ras	ras	NN	I-NP
O	75	76	-	-	HYPH	I-NP
O	76	77	1	1	CD	I-NP
O	77	78	-	-	HYPH	I-NP
O	78	89	transformed	transform	VBN	I-NP
B-Cell	90	93	rat	rat	NN	I-NP
I-Cell	93	94	-	-	HYPH	O
I-Cell	94	95	1	1	CD	B-NP
I-Cell	96	101	cells	cell	NNS	I-NP
O	102	105	and	and	CC	O
O	106	111	early	early	JJ	B-NP
O	111	112	-	-	HYPH	I-NP
O	112	119	passage	passage	NN	I-NP
O	120	123	rat	rat	NN	I-NP
B-Cell	124	133	embryonic	embryonic	JJ	I-NP
I-Cell	134	145	fibroblasts	fibroblast	NNS	I-NP
O	145	146	.	.	.	O

B-Cell	148	151	Rat	Rat	NN	B-NP
I-Cell	151	152	-	-	HYPH	B-NP
I-Cell	152	153	1	1	CD	I-NP
I-Cell	154	159	cells	cell	NNS	I-NP
O	160	165	which	which	WDT	B-NP
O	166	169	had	have	VBD	B-VP
O	170	174	been	be	VBN	I-VP
O	175	186	transformed	transform	VBN	I-VP
O	187	191	with	with	IN	B-PP
O	192	195	the	the	DT	B-NP
O	196	205	activated	activate	VBN	I-NP
O	206	208	Ha	Ha	NN	I-NP
O	208	209	-	-	HYPH	B-NP
O	209	212	ras	ras	NN	I-NP
O	212	213	-	-	SYM	I-NP
O	213	214	1	1	CD	I-NP
O	215	219	gene	gene	NN	I-NP
O	220	224	from	from	IN	B-PP
O	225	230	human	human	JJ	B-NP
B-Cell	231	233	EJ	EJ	NN	I-NP
I-Cell	234	241	bladder	bladder	NN	I-NP
I-Cell	242	251	carcinoma	carcinoma	NN	I-NP
I-Cell	252	257	cells	cell	NNS	I-NP
O	258	262	were	be	VBD	B-VP
O	263	268	fused	fuse	VBN	I-VP
O	269	273	with	with	IN	B-PP
O	274	281	diploid	diploid	JJ	B-NP
B-Cell	282	291	embryonic	embryonic	JJ	I-NP
I-Cell	292	295	rat	rat	NN	I-NP
I-Cell	296	307	fibroblasts	fibroblast	NNS	I-NP
O	307	308	.	.	.	O

O	309	313	Four	Four	CD	B-NP
O	314	322	selected	select	VBN	I-NP
B-Cell	323	327	cell	cell	NN	I-NP
I-Cell	328	335	hybrids	hybrid	NNS	I-NP
O	336	345	expressed	express	VBD	B-VP
O	346	349	the	the	DT	B-NP
O	350	355	human	human	JJ	I-NP
O	356	368	transforming	transform	VBG	I-NP
O	369	373	gene	gene	NN	I-NP
O	374	381	product	product	NN	I-NP
O	382	385	p21	p21	NN	I-NP
O	386	388	at	at	IN	B-PP
O	389	395	levels	level	NNS	B-NP
O	396	398	of	of	IN	B-PP
O	399	401	10	10	CD	B-NP
O	402	404	to	to	TO	I-NP
O	405	407	30	30	CD	I-NP
O	407	408	%	%	NN	I-NP
O	409	417	compared	compare	VBN	B-PP
O	418	420	to	to	TO	B-PP
O	421	424	100	100	CD	B-NP
O	424	425	%	%	NN	I-NP
O	426	428	in	in	IN	B-PP
O	429	432	the	the	DT	B-NP
O	433	444	transformed	transform	VBN	I-NP
O	445	453	parental	parental	JJ	I-NP
B-Cell	454	459	cells	cell	NNS	I-NP
O	459	460	.	.	.	O

O	461	464	The	The	DT	B-NP
B-Cell	465	471	hybrid	hybrid	JJ	I-NP
I-Cell	472	477	cells	cell	NNS	I-NP
O	477	478	,	,	,	O
O	479	486	however	however	RB	B-ADVP
O	486	487	,	,	,	O
O	488	497	exhibited	exhibit	VBD	B-VP
O	498	504	normal	normal	JJ	B-NP
O	505	515	morphology	morphology	NN	I-NP
O	515	516	,	,	,	O
O	517	526	anchorage	anchorage	NN	B-NP
O	527	538	requirement	requirement	NN	I-NP
O	539	542	for	for	IN	B-PP
O	543	556	proliferation	proliferation	NN	B-NP
O	556	557	,	,	,	O
O	558	561	and	and	CC	O
O	562	569	largely	largely	RB	B-VP
O	570	578	extended	extend	VBN	I-VP
O	579	586	latency	latency	NN	B-NP
O	587	594	periods	period	NNS	I-NP
O	595	597	of	of	IN	B-PP
O	598	612	tumorigenicity	tumorigenicity	NN	B-NP
O	613	615	in	in	IN	B-PP
O	616	623	newborn	newborn	JJ	B-NP
O	624	628	rats	rat	NNS	I-NP
O	628	629	.	.	.	O

O	630	641	Tumorigenic	Tumorigenic	JJ	B-NP
B-Cell	642	648	hybrid	hybrid	NN	I-NP
I-Cell	649	660	derivatives	derivative	NNS	I-NP
O	661	670	contained	contain	VBD	B-VP
O	671	676	lower	low	JJR	B-NP
O	677	684	numbers	number	NNS	I-NP
O	685	687	of	of	IN	B-PP
B-Cellular_component	688	699	chromosomes	chromosome	NNS	B-NP
O	700	704	than	than	IN	B-PP
O	705	708	the	the	DT	B-NP
O	709	719	tetraploid	tetraploid	JJ	I-NP
B-Cell	720	728	parental	parental	JJ	I-NP
I-Cell	729	736	hybrids	hybrid	NNS	I-NP
O	736	737	.	.	.	O

O	738	741	DNA	DNA	NN	B-NP
O	742	744	of	of	IN	B-PP
O	745	748	the	the	DT	B-NP
O	749	752	non	non	AFX	I-NP
O	752	753	-	-	HYPH	I-NP
O	753	764	tumorigenic	tumorigenic	JJ	I-NP
B-Cell	765	769	cell	cell	NN	I-NP
I-Cell	770	777	hybrids	hybrid	NNS	I-NP
O	778	789	transformed	transform	VBD	B-VP
B-Cell	790	793	Rat	Rat	NN	B-NP
I-Cell	793	794	-	-	HYPH	B-NP
I-Cell	794	795	1	1	CD	I-NP
I-Cell	796	801	cells	cell	NNS	I-NP
O	802	804	to	to	TO	B-PP
O	805	814	anchorage	anchorage	NN	B-NP
O	814	815	-	-	HYPH	B-NP
O	815	826	independent	independent	JJ	I-NP
O	827	840	proliferation	proliferation	NN	I-NP
O	841	843	as	as	IN	B-SBAR
O	844	852	expected	expect	VBN	B-VP
O	853	856	for	for	IN	B-PP
O	857	860	the	the	DT	B-NP
O	861	873	transforming	transform	VBG	I-NP
O	874	879	human	human	JJ	I-NP
O	880	882	Ha	Ha	NN	I-NP
O	882	883	-	-	HYPH	I-NP
O	883	886	ras	ras	NN	I-NP
O	887	891	gene	gene	NN	I-NP
O	892	899	present	present	JJ	B-ADJP
O	900	902	in	in	IN	B-PP
O	903	906	the	the	DT	B-NP
O	907	912	donor	donor	NN	I-NP
O	913	916	DNA	DNA	NN	I-NP
O	916	917	.	.	.	O

O	918	920	We	We	PRP	B-NP
O	921	929	conclude	conclude	VBP	B-VP
O	930	934	that	that	IN	B-SBAR
O	935	938	the	the	DT	B-NP
O	939	951	transforming	transform	VBG	I-NP
O	952	962	properties	property	NNS	I-NP
O	963	965	of	of	IN	B-PP
O	966	969	the	the	DT	B-NP
O	970	979	activated	activate	VBN	I-NP
O	980	982	Ha	Ha	NN	I-NP
O	982	983	-	-	HYPH	I-NP
O	983	986	ras	ras	NN	I-NP
O	987	991	gene	gene	NN	I-NP
O	992	994	in	in	IN	B-PP
B-Cell	995	998	Rat	Rat	NN	B-NP
I-Cell	998	999	-	-	HYPH	B-NP
I-Cell	999	1000	1	1	CD	I-NP
I-Cell	1001	1006	cells	cell	NNS	I-NP
O	1007	1010	can	can	MD	B-VP
O	1011	1013	be	be	VB	I-VP
O	1014	1024	suppressed	suppress	VBN	I-VP
O	1025	1027	at	at	IN	B-PP
O	1028	1031	the	the	DT	B-NP
O	1032	1036	post	post	AFX	I-NP
O	1036	1037	-	-	HYPH	I-NP
O	1037	1050	translational	translational	JJ	I-NP
O	1051	1056	level	level	NN	I-NP
O	1057	1059	by	by	IN	B-PP
O	1060	1063	the	the	DT	B-NP
O	1064	1072	presence	presence	NN	I-NP
O	1073	1075	of	of	IN	B-PP
O	1076	1079	the	the	DT	B-NP
O	1080	1086	genome	genome	NN	I-NP
O	1087	1091	from	from	IN	B-PP
O	1092	1099	diploid	diploid	JJ	B-NP
B-Cell	1100	1109	embryonic	embryonic	JJ	I-NP
I-Cell	1110	1113	rat	rat	NN	I-NP
I-Cell	1114	1125	fibroblasts	fibroblast	NNS	I-NP
O	1126	1129	but	but	CC	O
O	1130	1140	additional	additional	JJ	B-NP
O	1141	1149	controls	control	NNS	I-NP
O	1150	1152	of	of	IN	B-PP
O	1153	1163	expression	expression	NN	B-NP
O	1164	1166	of	of	IN	B-PP
O	1167	1170	the	the	DT	B-NP
O	1171	1183	transforming	transform	VBG	I-NP
O	1184	1188	gene	gene	NN	I-NP
O	1189	1192	are	be	VBP	B-VP
O	1193	1199	likely	likely	JJ	B-ADJP
O	1200	1202	to	to	TO	B-VP
O	1203	1208	exist	exist	VB	I-VP
O	1208	1209	.	.	.	O

O	1210	1216	Normal	Normal	JJ	B-NP
B-Cell	1217	1222	cells	cell	NNS	I-NP
O	1223	1230	contain	contain	VBP	B-VP
O	1231	1241	suppressor	suppressor	NN	B-NP
O	1242	1246	gene	gene	NN	I-NP
O	1246	1247	(	(	(	I-NP
O	1247	1248	s	s	NNS	I-NP
O	1248	1249	)	)	)	O
O	1250	1255	which	which	WDT	B-NP
O	1256	1265	safeguard	safeguard	VBD	B-VP
O	1266	1271	these	these	DT	B-NP
B-Cell	1272	1277	cells	cell	NNS	I-NP
O	1278	1285	against	against	IN	B-PP
O	1286	1300	transformation	transformation	NN	B-NP
O	1301	1303	by	by	IN	B-PP
O	1304	1307	the	the	DT	B-NP
O	1308	1315	product	product	NN	I-NP
O	1316	1318	of	of	IN	B-PP
O	1319	1322	the	the	DT	B-NP
O	1323	1335	transforming	transform	VBG	I-NP
O	1336	1338	Ha	Ha	NN	I-NP
O	1338	1339	-	-	HYPH	B-NP
O	1339	1342	ras	ras	NN	I-NP
O	1342	1343	-	-	SYM	B-NP
O	1343	1344	1	1	CD	I-NP
O	1345	1353	oncogene	oncogene	NN	I-NP
O	1353	1354	.	.	.	O

